Milestone Pharmaceuticals Inc. MIST
Set alert
0.72 USD -0.01 -1.22%
At close · Nov 2
0.75 +0.03 +4.01%
After hours · Nov 2, 6:15 PM ET
0.7202 Day range 0.7799
0.631 52-week range 3.06
- YTD
- -64.30%
- 1 year
- -62.44%
- Open
- 0.7708
- Prev close
- 0.73
- Mkt cap
- 89.78M
- Vol
- 748.84K
- Avg vol
- 1.35M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7202
- High
- 0.7799
- Forward P/E
- -2.15
- Beta
- 1.73
- Short ratio
- 2.46
- Inst. own
- 57.01%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 1.71
- 200-d avg
- 1.58
- 1y target
- 10.25
5D chart
Signals (124)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 4:00 PM | 9 hours ago |
| RSI: Oversold | Nov 2, 3:40 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 9 hours ago |
| SMA: Bearish | Nov 2, 3:15 PM | 10 hours ago |
| MACD: Sell Signal | Nov 2, 3:15 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 2:50 PM | 10 hours ago |
| SMA: Bullish | Nov 2, 2:30 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:25 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:20 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 1:30 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 1:30 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 1:30 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 12:50 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 12:20 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 11:40 AM | 13 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 14 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 15 hours ago |
| SMA: Bearish | Nov 2, 10:30 AM | 15 hours ago |
Newest 20 of 124.
Financial health
Altman Z-Score
-3.68 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -2.7×
FY 2017 5y median -2.9× FY 2025
P/S 110×
FY 2017 5y median 33.6× FY 2025
P/B 4.1×
FY 2017 5y median 4.1× FY 2025
P/FCF -3.4×
FY 2017 5y median -3.4× FY 2025
EV/EBITDA -2.6×
FY 2017 5y median -2.8× FY 2025
EV/Sales 100×
FY 2017 5y median 32.6× FY 2025
FCF Yield -29.1%
FY 2017 5y median -29.1% FY 2025
Profitability
Gross Margin 92.6%
FY 2017 5y median 100.0% FY 2025
Operating Margin -4041.7%
FY 2017 5y median -1192.8% FY 2025
Net Margin -4078.8%
FY 2017 5y median -1167.8% FY 2025
ROE -151.0%
FY 2017 5y median -151.0% FY 2025
ROIC -62.0%
FY 2017 5y median -62.0% FY 2025
ROA -55.5%
FY 2017 5y median -55.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2017 FY 2025
Operating Income -48.4%
FY 2017 FY 2025
EPS (diluted) -11.9%
FY 2017 FY 2025
Free Cash Flow -70.8%
FY 2017 FY 2025
Financial Health
Current Ratio 8.0×
FY 2017 5y median 10.1× FY 2025
Quick Ratio 8.0×
FY 2017 5y median 10.1× FY 2025
Debt / Equity 1.4×
FY 2017 5y median 1.4× FY 2025
Net Debt / EBITDA 0.2×
FY 2017 5y median 0.1× FY 2025
Interest Coverage -16.3×
FY 2017 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
